Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. - Degorce SL; Aagaard A; Anjum R; Cumming IA; Diène CR; Fallan C; Johnson T; Leuchowius KJ; Orton AL; Pearson S; Robb GR; Rosen A; et al. (Bioorganic & medicinal chemistry, 2020)